Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10556908
APP PUB NO 20190106426A1
SERIAL NO

16130801

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to imidazo[1,2-a]pyrazine derivatives of Formula I, or a pharmaceutically acceptable salt thereof, which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INCYTE HOLDINGS CORPORATION1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
INCYTE CORPORATION1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Courter, Joel R Wilmington, US 17 410
He, Chunhong Chadds Ford, US 102 2747
Li, Jingwei Westfield, US 58 1195
Lu, Liang Hockessin, US 118 2257
Sun, Yaping Lansdale, US 31 804
Wang, Xiaozhao Mt. Laurel, US 87 982
Wu, Liangxing Wilmington, US 162 5431
Yao, Wenqing Chadds Ford, US 324 9447
Zhang, Colin Berwyn, US 57 1647
Zhuo, Jincong Garnet Valley, US 115 3059

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 11, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 11, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00